Technology | May 08, 2015

Medtronic Announces FDA Clearance and U.S. Launch of Euphora Semicompliant Coronary Balloon

Company also launches “Cath Lab Connect” informational portal and community website for cath lab professionals

Medtronic, Euphora, SC, semicompliant balloon dilatation catheter, FDA, U.S.

May 8, 2015 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buildup. The first patient case with the Euphora Semicompliant Balloon Catheter was recently performed by James T. DeVries, M.D., FACC, FSCAI, director of endovascular intervention and associate director of the Cardiac Catheterization Lab at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

“We at Dartmouth-Hitchcock Medical Center are pleased to have been chosen as the U.S. launch site for the Medtronic Euphora balloon,” said DeVries. “This continued access to new technology is essential to help our patients in the ongoing battle against coronary artery disease.”

Pre-dilatation with a semicompliant balloon helps physicians determine lesion characteristics and stent selection, and facilitates stent access to the lesions – a crucial step for patients with challenging lesions.

The device features several new design advancements including:

  • Delivery system with PowerTrac technology to provide superior deliverability through challenging lesions. This enhanced pushability comes from a redesigned shaft technology first introduced with the Medtronic NC Euphora Noncompliant Balloon Dilatation Catheter in September 2014­;
  • Ultra-slim balloon material, a tapered proprietary inner shaft design and an optimized mini-wrap to reduce the wall thickness of the balloon and contribute to the extremely low crossing profile; 
  • Improved insertion and retraction force to enhance navigation to lesion sites when using the Kissing Balloon Technique; and
  • Packaging enhancements for quicker and easier identification by cath lab staff due to new product labeling and EZ Pull Corners, as well as reduced box size for optimal shelf storage.

 

In an effort to increase education and peer-to-peer engagement among cath lab professionals, Medtronic also announced it will launch “Cath Lab Connect,” an informational portal and community website dedicated to cath lab nurses and technicians. The website, which will go live in May, will feature educational resources for cath lab professionals, information about upcoming events and conferences, industry news, as well as a forum for members to connect and discuss relevant topics or share best practices.

For more information: www.medtronic.com


Related Content

News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Subscribe Now